PMID: 26259804

Authors:

Bagdanoff JT, Jain R, Han W, Zhu S, Madiera AM, Lee PS, Ma X, Poon D

Title:

Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase.

Journal:

Bioorg Med Chem Lett. 2015 Sep 15;25(18):3788-92. doi:, 10.1016/j.bmcl.2015.07.091. Epub 2015 Jul 30.

Abstract:

A series of structure based drug design hypotheses and focused screening efforts led to the identification of tetrahydropyrrolo-diazepenones with striking potency against ERK2 kinase. The role of fluorination in mitigating microsomal clearance was systematically explored. Ultimately, it was found that fluorination of a cyclopentanol substructure provided significant improvement in both potency and human metabolic stability.